Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank71
3Y CAGR+2.3%
5Y CAGR-2.3%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+2.3%/yr
vs -1.6%/yr prior
5Y CAGR
-2.3%/yr
Recent acceleration
Acceleration
+3.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.13M | +0.2% |
| 2024 | $18.09M | -3.6% |
| 2023 | $18.76M | +10.7% |
| 2022 | $16.95M | +125.2% |
| 2021 | $7.53M | -63.1% |
| 2020 | $20.38M | +75.3% |
| 2019 | $11.63M | -35.6% |
| 2018 | $18.04M | -17.9% |
| 2017 | $21.98M | +10.0% |
| 2016 | $19.98M | - |